Page 42 - Mployee Wellness Programs News Today

TEFCA’s goal is to establish a universal floor for interoperability across the country by developing the infrastructure model and governing approach for users in different networks to securely share basic clinical information with each other.

Selection of the correct wound dressings and closure devices for patients remains an important factor in preventing MARSIs (Medical Adhesive Related Skin Injuries).

Although problems in US healthcare abound, the most insidious challenges are often tightly coupled with the industry’s most appealing and instilled virtues — a highly selective and independent workforce, (b) an extremely low tolerance for risk, and (c) a high degree of professional oversight.

Shifting the healthcare system to an upstream approach will take a lot of work, but young people desperately need it, and the healthcare system direly needs it as well.

The first gene therapies for sickle cell disease are now approved: Casgevy from Vertex Pharmaceuticals Casgevy and Lyfgenia from Bluebird Bio. Despite the same-day approval, key differences give one of these therapies commercialization advantages over the other.

Looking back 20 years, when fewer than 18% of physician practices used electronic health records, few experts would have anticipated how information technology has changed healthcare. Thanks to IT, the volume and types of data generated and the speed at which they can be analyzed are vastly different than decades ago.

Embracing the possibilities that AI unlocks, our commitment to seamlessly integrating AI into healthcare workflows reflects our belief that technology should melt into the background, empowering human caregivers to focus on delivering compassionate patient care.

During a webinar, three health system leaders discussed strategies they use to ensure successful AI deployment. They agreed that one of the best ways health systems can prime themselves for fruitful AI deployments is beginning with a specific problem to solve — as opposed to having AI startups tell them which problems need to be addressed.

Researchers recently tested ChatGPT’s ability to answer patient questions about medication, finding that the AI model gave wrong or incomplete answers about 75% of the time. Providers should be wary of the fact that the model does not always give sound medical advice, given many of their patients could be turning to ChatGPT to answer health-related questions.

Check out news from FreezeNit, Vascular Perfusion Solutions, Kandu, and BetterYou.